ArticleJournal of multidisciplinary healthcare2026
Development of a Panvascular Health Promotion and Risk Stratification Tool for Community Screening: Grounded in Four-Level Disease Prevention Theory.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Panvascular disease, mainly characterized by atherosclerosis involving multiple vascular territories, poses significant morbidity and mortality risks. Early detection enables timely intervention, yet existing screening tools target single diseases, rely on expensive equipment, and are impractical for panvascular risk stratification in community settings. Based on the four-level disease prevention framework, we developed a questionnaire-based panvascular health promotion and risk stratification tool to enhance awareness and risk categorization among community residents. Methods: From March to May 2024, we performed a thorough literature search to identify panvascular risk factors and characteristics. Semi-structured interviews with community health staff explored current tools' advantages, limitations, and improvement suggestions, yielding an initial 118-item draft. Between June and August 2024, two rounds of expert consultations refined the tool for importance, feasibility, and validity, resulting in a 31-item final version. Results: The tool features three sequential screening steps with four categories of risk prevention and management. Step 1 (tertiary prevention) screens for 13 serious vascular events. If any item is positive, screening terminates (a "stop when positive" rule) and the individual is classified into the tertiary risk group. Step 2 (secondary prevention) assesses nine high-risk characteristics. Step 3 (primary/primordial prevention) evaluates nine general risk factors. It supports physician-led or self-administered use, supplemented by basic tests like blood pressure and lipid measurements. Validity will be assessed by promotion of healthcare-seeking behavior and alignment with clinical diagnosis. Conclusion: This is the first integrated tool combining four-level prevention with panvascular risk stratification via a stepwise pathway. It empowers community residents for proactive vascular health management and risk categorization. Future validation studies are needed to verify its performance in increasing early awareness, diagnosis, and management of panvascular disease in community settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.